BREAKING NEWS

Coronavirus forces Diabetes UK to cancel conference

Diabetes UK has cancelled its annual conference and all associated events in Glasgow because of the coronavirus situation. 

The three-day event was due to start on Wednesday, March 18.

Read more
 

Diabetes UK issues advice on coronavirus

Diabetes UK has issued advice on the coronavirus warning people it can cause “severe symptoms and complications in people with diabetes”.

In a post on its website, the organisation said it has pulled together a number of resources to help people with diabetes who have been concerned about the global outbreak. The charity said a number of people had been in touch “looking for advice”.

Read more
 

Experts asked to review newly drafted Low Carb Public Health document

Experts with a scientific background are being asked to review a draft report about the low carb diet and type 2 diabetes published on behalf of the government.

The request comes as Public Health England (PHE) invited the Scientific Advisory Committee on Nutrition (SACN) to review the best available evidence around on low carbohydrate diets in a bid to update current UK government advice for people with type 2 diabetes.

Read more
 

Half of GPs skip recommended diabetes related kidney tests

More than half (54%) of GPs and nurses who treat people with type 2 diabetes do not carry out the recommended annual Urine Albumin-to-Creatinine Ratio (UACR) test, according to a new survey.

The test, which is used to detect kidney damage that can lead to fatal complications, should be conducted every year, as it can provide a ‘window of opportunity’ where the rate of kidney damage can be slowed or even halted with the right treatment and lifestyle changes.

Read more
 

Empagliflozin and dulaglutide are most prescribed drugs in USA for type 2

Empagliflozin and dulaglutide were the most-prescribed drugs in their respective classes for treating type 2 diabetes in the United States between 2013 and 2018, new research has shown. 

Among people initiating oral sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) over the five year period, empagliflozin (Jardiance, Boehringer Ingelheim/Lilly) became the most commonly prescribed glucose-lowering drug.

Read more
 

Record high two million people at risk of type 2 diabetes

Around two million people in England are at risk of developing type 2 diabetes, the highest on record, according to newly released NHS figures. To read more, click here.

Diabetes-related lower limb amputations up by 18%

Diabetes-related lower limb amputations have increased by 18.3% after 27,465 operations were carried out in England between 2015 and 2018. To read more, click here.

Dentists could help identify type 2 diabetes in people

Dental teams could play an integral role in identifying people at high risk of developing type 2 diabetes, according to new research. To read more, click here. 

 

Event focusing on diabetes in older people is announced

Healthcare professionals with an interest in older people with diabetes have the opportunity to sign up to attend a well-established annual one-day conference dedicated to the subject.

Read more
 
 

Bringing you the latest jobs from around the country within the field of diabetes.

Paediatric Diabetes Specialist Nurses – Southport and Ormskirk Hospital NHS Trust

Diabetes Specialist Nurse – Croydon Health Services NHS Trust

Diabetes Consultant – Chesterfield Royal Hospital NHS Foundation Trust

Endocrine Specialist Nurse – St George's University Hospitals NHS Foundation Trust

 

With thanks to our sponsors

 

Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.

We are now on YouTube where you will find interviews with leading people within the field of diabetes. Click here to visit our page. 

 
FacebookTwitterWebsite
The Diabetes Times
Catherine House
Harborough Road
Brixworth
Northamptonshire
NN6 9BX
  Like 
  Tweet 
  Share 
  Forward 
Preferences  |  Unsubscribe